Market Overview:
The global oligonucleotide pool market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for oligonucleotide pools for diagnostics, therapeutics, and research applications. Additionally, the growing demand for personalized medicines is also contributing to the growth of this market. However, stringent regulatory requirements and high costs associated with R&D are restraining the growth of this market. The DNA pool segment is expected to account for the largest share of the global oligonucleotide pool market in 2018. This segment is anticipated to grow at a CAGR of 11% during the forecast period from 2018 to 2030 owing to its widespread use in diagnostics and research applications.
Product Definition:
An oligonucleotide pool is a collection of different oligonucleotides. Oligonucleotide pools are often used in research to study the effects of different sequences on a particular process or to identify potential binding sites for a protein.
DNA Pool:
DNA pool is a collection of DNA fragments that are extracted from different sources. It is used as a raw material for the synthesis of oligonucleotides. Oligonucleotide, also known as nucleic acid or gene silencing drug, is an artificial molecule made from short pieces (oligos) of DNA.
RNA Pool:
RNA pool is a collection of small RNA molecules that are extracted from cells and other natural sources. Small RNAs such as miRNAs and lncRNAs play an important role in the development of cancer, differentiation, apoptosis resistance, etc. Therefore, it becomes essential to screen various types of small RNAs for their specific targets during the process of drug discovery & development.
Application Insights:
Diagnostics segment held the largest market share in 2017. This is attributed to extensive usage of oligonucleotides for diagnosing diseases and monitoring their progression. The use of these molecules as a tool for disease diagnosis has been recognized by the WHO as well as other regulatory agencies such as EMA and FDA. Owing to increasing adoption of diagnostic tests, particularly molecular tests, oligonucleotide pools are expected to witness lucrative growth over the forecast period.
Therapeutics is another promising application owing to growing recognition of benefits associated with these compounds, including improved treatment outcomes in cancer patients and reduction in side effects caused due both genetic mutations & cell death.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare infrastructure, favorable government policies and increasing demand for cost-effective therapeutics are some of the major factors contributing to its growth. In addition, growing research activities on RNAi and other innovative techniques to overcome drug resistance is expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising investments by governments in developing countries such as China and India coupled with increasing R&D expenditure by pharmaceutical companies seeking new treatment options for chronic diseases such as cancer, diabetes & HIV/Aids etc. Moreover, a large population base suffering from genetic disorders or undergoing medical treatments would also support regional market growth during the estimated time span.
Growth Factors:
- Increasing demand for personalized medicines
- Growing number of cancer patients
- Rising prevalence of genetic disorders
- Technological advancements in oligonucleotide synthesis and detection methods
- Growing investments in R&D
Scope Of The Report
Report Attributes
Report Details
Report Title
Oligonucleotide Pool Market Research Report
By Type
DNA Pool, RNA Pool
By Application
Diagnostics, Therapeutics, Research, Others
By Companies
Agilent Technologies, Creative Biogene, CustomArray, Integrated DNA Technologies, MYcroarray, Sigma Aldrich, TriLink BioTechnologies, Twist Bioscience
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
190
Number of Tables & Figures
133
Customization Available
Yes, the report can be customized as per your need.
Global Oligonucleotide Pool Market Report Segments:
The global Oligonucleotide Pool market is segmented on the basis of:
Types
DNA Pool, RNA Pool
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostics, Therapeutics, Research, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agilent Technologies
- Creative Biogene
- CustomArray
- Integrated DNA Technologies
- MYcroarray
- Sigma Aldrich
- TriLink BioTechnologies
- Twist Bioscience
Highlights of The Oligonucleotide Pool Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DNA Pool
- RNA Pool
- By Application:
- Diagnostics
- Therapeutics
- Research
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oligonucleotide Pool Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oligonucleotide pool is a collection of oligonucleotides that are used for sequencing.
Some of the key players operating in the oligonucleotide pool market are Agilent Technologies, Creative Biogene, CustomArray, Integrated DNA Technologies, MYcroarray, Sigma Aldrich, TriLink BioTechnologies, Twist Bioscience.
The oligonucleotide pool market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Oligonucleotide Pool Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Oligonucleotide Pool Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Oligonucleotide Pool Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Oligonucleotide Pool Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Oligonucleotide Pool Market Size & Forecast, 2018-2028
4.5.1 Oligonucleotide Pool Market Size and Y-o-Y Growth
4.5.2 Oligonucleotide Pool Market Absolute $ Opportunity
Chapter 5 Global Oligonucleotide Pool Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Oligonucleotide Pool Market Size Forecast by Type
5.2.1 DNA Pool
5.2.2 RNA Pool
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Oligonucleotide Pool Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Oligonucleotide Pool Market Size Forecast by Applications
6.2.1 Diagnostics
6.2.2 Therapeutics
6.2.3 Research
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Oligonucleotide Pool Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Oligonucleotide Pool Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Oligonucleotide Pool Analysis and Forecast
9.1 Introduction
9.2 North America Oligonucleotide Pool Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Oligonucleotide Pool Market Size Forecast by Type
9.6.1 DNA Pool
9.6.2 RNA Pool
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Oligonucleotide Pool Market Size Forecast by Applications
9.10.1 Diagnostics
9.10.2 Therapeutics
9.10.3 Research
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Oligonucleotide Pool Analysis and Forecast
10.1 Introduction
10.2 Europe Oligonucleotide Pool Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Oligonucleotide Pool Market Size Forecast by Type
10.6.1 DNA Pool
10.6.2 RNA Pool
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Oligonucleotide Pool Market Size Forecast by Applications
10.10.1 Diagnostics
10.10.2 Therapeutics
10.10.3 Research
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Oligonucleotide Pool Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Oligonucleotide Pool Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Oligonucleotide Pool Market Size Forecast by Type
11.6.1 DNA Pool
11.6.2 RNA Pool
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Oligonucleotide Pool Market Size Forecast by Applications
11.10.1 Diagnostics
11.10.2 Therapeutics
11.10.3 Research
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Oligonucleotide Pool Analysis and Forecast
12.1 Introduction
12.2 Latin America Oligonucleotide Pool Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Oligonucleotide Pool Market Size Forecast by Type
12.6.1 DNA Pool
12.6.2 RNA Pool
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Oligonucleotide Pool Market Size Forecast by Applications
12.10.1 Diagnostics
12.10.2 Therapeutics
12.10.3 Research
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Oligonucleotide Pool Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Oligonucleotide Pool Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Oligonucleotide Pool Market Size Forecast by Type
13.6.1 DNA Pool
13.6.2 RNA Pool
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Oligonucleotide Pool Market Size Forecast by Applications
13.10.1 Diagnostics
13.10.2 Therapeutics
13.10.3 Research
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Oligonucleotide Pool Market: Competitive Dashboard
14.2 Global Oligonucleotide Pool Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Agilent Technologies
14.3.2 Creative Biogene
14.3.3 CustomArray
14.3.4 Integrated DNA Technologies
14.3.5 MYcroarray
14.3.6 Sigma Aldrich
14.3.7 TriLink BioTechnologies
14.3.8 Twist Bioscience
